Novel methods of treating hearing loss
US-2024390323-A1 · Nov 28, 2024 · US
US9446006B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9446006-B2 |
| Application number | US-201414450073-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 1, 2014 |
| Priority date | Apr 17, 2009 |
| Publication date | Sep 20, 2016 |
| Grant date | Sep 20, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Hydroxytyrosol or olive juice containing hydroxytyrosol in combination with at least one of the compounds selected from the group consisting of: creatine, coenzyme Q10, resveratrol, caffeine, carnitine, B vitamins (B1, B2, B3, B5, B6, and/or B12) and ginseng (preferably: root) extract.can be used to maintain or increase mitochondrial biogenesis in cardiac muscle, skeletal muscles, and liver tissue.
Opening claim text (preview).
What is claimed is: 1. A method of increasing mitochondria biogenesis in a mammal comprising: (a) administering to the mammal in need of increased mitochondria biogenesis an effective amount of a composition comprising a dosage amount of 10-200 mg of hydroxytyrosol in combination with a dosage amount of 50-450 mg of caffeine; and (b) observing a mitochondria biogenesis effect. 2. The method according to claim 1 , wherein the hydroxytyrosol is from an olive extract. 3. The method according to claim 1 , wherein the composition is a nutraceutical or food composition. 4. The method according to claim 1 , wherein the composition is a veterinary composition. 5. The method according to claim 1 , wherein the mitochondria biogenesis effect comprises observations that the method helps reduce muscle fatigue; helps reduce muscle soreness; complements an immediate short term effect of caffeine with a sustained effect on energy generation; helps promote energy generation from fat; helps lower plasma lactate during exercise; helps maintain muscle force in conditions of oxidative stress; helps protect against exercise-induced oxidative stress; helps the body to find more energy without getting too much caffeine; gives long-lasting energy; helps boost body's own energy production; helps maintain more even energy levels throughout the day; provide for immediate and sustained energy; helps the body to adapt to exercise; helps prepare the body for exercise goals; helps revamp the body's shape; facilitates a restart of an exercise program; helps one to get going again; helps one feel more energetic; helps one feel more active; supports one's zest for action; helps one cope with a busy lifestyle; increased muscle work capacity; improved aerobic capacity; enhanced physical performance; enhanced exercise performance; improved running endurance; improved running distance and/or improved running time; or stimulates energy formation from nutrients. 6. The method according to claim 5 , wherein the composition is a veterinary composition.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Anorexiants; Antiobesity agents · CPC title
Nutrients, e.g. vitamins, minerals · CPC title
Drugs for disorders of the muscular or neuromuscular system · CPC title
for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.